Active Pharmaceutical Ingredients (APIs) play a pivotal role in pharmacodynamics, the study of how drugs exert their therapeutic effects on the body. These biologically active components are the core elements responsible for the physiological changes resulting from drug administration. By interacting with specific molecular targets, such as receptors or enzymes, APIs modulate cellular and biochemical processes, ultimately influencing the desired therapeutic outcomes.
Understanding the pharmacodynamics of APIs is crucial for determining the drug's efficacy, potency, and safety profile. It involves unraveling the intricate mechanisms by which these substances engage with biological systems, leading to a comprehensive comprehension of their therapeutic impact. Pharmacodynamic studies not only aid in optimizing drug dosages but also contribute to the development of safer and more effective pharmaceutical interventions. As researchers delve deeper into the dynamic interplay between APIs and the human body, advancements in pharmacology continue to pave the way for innovative and targeted therapeutic solutions.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico